ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,767Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 252

$294K Total Retail Price of All Prescriptions

Rank: 161 out of 252

832 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 832 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,399 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
CEFUROXIME 525 441 10 1 114
MELOXICAM 242 197 2 20
LISINOPRIL 233 198 3 3
SIMVASTATIN 229 195 4 2
AMLODIPINE BESYLATE 200 183 5 4
METOPROLOL TARTRATE 198 180 6 10
TRAMADOL HCL 192 169 7 17
HYDROCODONE-ACETAMINOPHEN 191 155 S3 8 5
AZITHROMYCIN 181 153 9 37
OMEPRAZOLE 180 143 10 6
LEVOTHYROXINE SODIUM 173 148 11 1
METFORMIN HCL 159 121 12 9
FUROSEMIDE 154 117 13 7
HYDROCHLOROTHIAZIDE 128 107 14 13
CITALOPRAM HBR 126 91 15 15
PROAIR HFA 126 110 15 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 93 15 25
ZOLPIDEM TARTRATE 108 65 18 21
CLONIDINE HCL 92 71 19 35
WARFARIN SODIUM 90 81 20 14
ALLOPURINOL 87 73 21 30
POTASSIUM CHLORIDE 79 59 22 8
LEVOFLOXACIN 78 69 23 79
ATORVASTATIN CALCIUM 68 46 24 16
AMOXICILLIN 68 52 24 122
DEXAMETHASONE 66 56 26 197
GLIPIZIDE ER 64 53 27 90
NEXIUM 64 48 27 23
FLUTICASONE PROPIONATE 62 57 29 36
GLIPIZIDE 60 60 30 52
AMITRIPTYLINE HCL 58 47 R 31 46
DIOVAN HCT 57 57 32 65
CRESTOR 57 56 32 34
PANTOPRAZOLE SODIUM 55 43 34 62
CIPROFLOXACIN HCL 55 48 34 61
MECLIZINE HCL 54 50 36 136
FLUCONAZOLE 53 39 37 185
ETODOLAC 53 44 37 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.